|
NCOA6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.020600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.813000E-01 |
| Normal-vs-Stage2 |
6.420600E-01 |
| Normal-vs-Stage3 |
5.047400E-01 |
| Normal-vs-Stage4 |
4.164000E-01 |
| Stage1-vs-Stage2 |
8.458000E-01 |
| Stage1-vs-Stage3 |
2.109200E-01 |
| Stage1-vs-Stage4 |
8.183400E-01 |
| Stage2-vs-Stage3 |
4.126400E-01 |
| Stage2-vs-Stage4 |
7.464600E-01 |
| Stage3-vs-Stage4 |
3.558000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.537800E-01 |
| Normal-vs-AfricanAmerican |
1.418570E-01 |
| Normal-vs-Asian |
1.307250E-01 |
| Caucasian-vs-AfricanAmerican |
2.584400E-01 |
| Caucasian-vs-Asian |
5.554400E-01 |
| AfricanAmerican-vs-Asian |
7.540600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.630410E-01 |
| Normal-vs-Female |
2.892800E-01 |
| Male-vs-Female |
2.638000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.499050E-01 |
| Normal-vs-Extreme_Weight |
3.424400E-02 |
| Normal-vs-Obese |
6.375400E-01 |
| Normal-vs-Extreme_Obese |
7.463500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.549000E-01 |
| Normal_Weight-vs-Obese |
1.252570E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.420200E-01 |
| Extreme_Weight-vs-Obese |
3.565600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.892200E-01 |
| Obese-vs-Extreme_Obese |
2.379000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.460200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.635000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.311600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.476000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.762000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.604800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.841000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.777200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.995000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.809200E-01 |
| Normal-VS-Type2 PRCC |
4.920200E-02 |
| Normal-VS-KIRP CIMP |
5.958200E-01 |
| Normal-VS-Unclassified PRCC |
6.393900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.857600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.847400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.019800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.658370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.720800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.035000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.298000E-02 |
| Normal-vs-N1 |
2.079400E-01 |
| Normal-vs-N2 |
2.550800E-01 |
| N0-vs-N1 |
2.507900E-02 |
| N0-vs-N2 |
9.927200E-01 |
| N1-vs-N2 |
2.948600E-01 |
|
|
